Authors:
DHAESE PC
COUTTENYE MM
GOODMAN WG
LEMONIATOU E
DIGENIS P
SOTORNIK I
FAGALDE A
BARSOUM RS
LAMBERTS LV
DEBROE ME
Citation: Pc. Dhaese et al., USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1874-1884
Authors:
DHAESE PC
COUTTENYE MM
LAMBERTS LV
GOODMAN WG
NUYTS GD
LEMONIATOU E
DIGENIS P
SOTORNIK I
FAGALDE A
DEBROE ME
Citation: Pc. Dhaese et al., VALUE OF THE LOW-DOSE DESFERRIOXAMINE (DFO) TEST IN THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE (ARBD) IN DIALYSIS (D) PATIENTS, Kidney international, 46(5), 1994, pp. 1461-1461
Authors:
DHAESE PC
LAMBERTS LV
VERPOOTEN GA
VANEERDEWEG W
JURGENS A
ARAKELIAN S
BABLOYAN A
DIGENIS P
TJALMA W
DEBROE ME
Citation: Pc. Dhaese et al., URINARY AND BILIARY-EXCRETION OF ALUMINOXAMINE AND FERRIOXAMINE IN DOGS WITH VARIOUS RENAL-FUNCTION, Kidney international, 45(1), 1994, pp. 76-84